Search

Search Constraints

You searched for: Author/Creator Bettelheim, Peter

Search Results

1. CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiation. (10th September 2018)

2. Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS‐Flow Cytometry Working Group. Issue 1 (13th December 2021)

3. Diagnosis, management and response criteria of iron overload in myelodysplastic syndromes (MDS): updated recommendations of the Austrian MDS platform. Issue 2 (1st February 2018)

4. ELN iMDS flow working group validation of the monocyte assay for chronic myelomonocytic leukemia diagnosis by flow cytometry. Issue 1 (30th December 2021)

5. Flow cytometric analysis of myelodysplasia: Pre‐analytical and technical issues—Recommendations from the European LeukemiaNet. Issue 1 (11th December 2021)

6. Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemia. (1st June 2021)

7. Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working group. Issue 1 (23rd November 2022)

8. Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group. Issue 1 (20th December 2022)

9. PD‐L1 overexpression correlates with JAK2‐V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms. Issue 4 (21st January 2022)

10. Phenotypic characterization of disease‐initiating stem cells in JAK2‐ or CALR‐mutated myeloproliferative neoplasms. Issue 5 (9th March 2023)